Hip Arthroscopy vs Total Hip Replacement for Hip Osteoarthritis
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Hip Arthroscopy vs Total Hip Replacement for Hip Osteoarthritis?
Is hip arthroscopy or total hip replacement generally safe for humans?
Hip arthroscopy is generally considered safe with a relatively low complication rate, though some complications may be underreported. Total hip replacement is a common follow-up procedure after hip arthroscopy, and while it can be more challenging if done after arthroscopy, it does not significantly affect clinical outcomes.678910
How does the treatment of hip arthroscopy differ from total hip replacement for hip osteoarthritis?
Hip arthroscopy is a minimally invasive procedure aimed at preserving the hip joint and is often used to treat hip pain and other issues before they become severe. In contrast, total hip replacement (also known as total hip arthroplasty) involves replacing the entire hip joint and is typically used when the joint is significantly damaged, such as in advanced osteoarthritis.2491112
What is the purpose of this trial?
The aim of the proposed study is to perform a comparative pilot, randomized controlled trial of hip arthroscopy versus definitive total hip arthroplasty (THA) for the treatment of early hip osteoarthritis (Tönnis Grade 1-2) in patients between the ages of 40-60 years.
Research Team
Ryan M Degen, MD
Principal Investigator
Fowler Kennedy Sport Medicine Clinic
Eligibility Criteria
This trial is for people aged 40-60 with early hip osteoarthritis (Tönnis Grade 1-2) who've tried non-surgical treatments for at least 3 months without relief. It's not suitable for those with advanced arthritis, pregnant women, prior hip replacements on the other side, or certain hip shapes that make surgery risky.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either hip arthroscopy or total hip arthroplasty based on randomization
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 6 weeks, 3, 6, and 12 months
Long-term cost-effectiveness analysis
Estimate the lifetime cost-effectiveness of arthroscopy vs THA using a Markov model
Treatment Details
Interventions
- Hip Arthroscopy
- Total Hip Arthroplasty
Hip Arthroscopy is already approved in European Union, United States, Canada, Japan for the following indications:
- Labral tears
- Femoroacetabular impingement (FAI)
- Synovitis
- Chondral lesions
- Loose bodies
- Labral tears
- Femoroacetabular impingement (FAI)
- Synovitis
- Chondral lesions
- Loose bodies
- Mild to moderate hip osteoarthritis
- Labral tears
- Femoroacetabular impingement (FAI)
- Synovitis
- Chondral lesions
- Loose bodies
- Labral tears
- Femoroacetabular impingement (FAI)
- Synovitis
- Chondral lesions
- Loose bodies
Find a Clinic Near You
Who Is Running the Clinical Trial?
Western University, Canada
Lead Sponsor